Page last updated: 2024-11-05

tranexamic acid and Foramen Ovale, Patent

tranexamic acid has been researched along with Foramen Ovale, Patent in 1 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Foramen Ovale, Patent: A condition in which the FORAMEN OVALE in the ATRIAL SEPTUM fails to close shortly after birth. This results in abnormal communications between the two upper chambers of the heart. An isolated patent ovale foramen without other structural heart defects is usually of no hemodynamic significance.

Research Excerpts

ExcerptRelevanceReference
"Tranexamic acid has been shown to reduce perioperative blood loss without increasing the risk of venous thromboembolism after total knee replacement."1.39Cerebrovascular infarction following bilateral total knee arthroplasty and tranexamic acid administration. ( Baker, J; Bruce-Brand, R; Dragomir, R; Harty, J, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruce-Brand, R1
Dragomir, R1
Baker, J1
Harty, J1

Other Studies

1 other study available for tranexamic acid and Foramen Ovale, Patent

ArticleYear
Cerebrovascular infarction following bilateral total knee arthroplasty and tranexamic acid administration.
    Acta orthopaedica Belgica, 2013, Volume: 79, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Cerebral Infar

2013